BIOMAT Database Logo BIOMAT Database Logo

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. 1983

H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen

The effect of early aggressive antihypertensive treatment on kidney function in diabetic nephropathy was studied prospectively in ten insulin-dependent diabetics (mean age 29 years). During the mean pretreatment period of 29 (range 23-38) months the glomerular filtration rate (GFR) decreased significantly and the urinary albumin excretion rate and arterial blood pressure rose significantly. During the 39 month (range 28-48) period of antihypertensive treatment with metoprolol, hydralazine, and frusemide (furosemide) or thiazide, arterial blood pressure fell from 144/97 mm Hg (mean of all pretreatment values) to 128/84 mm Hg (mean of all post-treatment values), urinary albumin excretion from 977 micrograms/min to 433 micrograms/min, and GFR from 80 to 62 ml/min/1 . 73 m2. The rate of decline in GFR decreased from 0.91 ml/min/month before treatment to 0.39 ml/min/month (range 0.08 to 0.68 ml/min/month) during treatment.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson

Related Publications

H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
December 1997, Kidney international. Supplement,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
Impact of hypertension and antihypertensive treatment on kidney function in diabetic nephropathy.
April 1994, Danish medical bulletin,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
Hypertension and nephrotoxicity in the rate of decline in kidney function in diabetic nephropathy.
January 1987, Clinical nephrology,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
[Antihypertensive treatment in diabetic nephropathy].
November 1979, Nordisk medicin,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
Combining antihypertensive agents in early diabetic nephropathy.
January 1990, The Journal of diabetic complications,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
Rate of decline in renal function in Indo-Asians and Whites with diabetic nephropathy.
January 1998, Diabetic medicine : a journal of the British Diabetic Association,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomes.
August 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomes.
January 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
Hypertension and antihypertensive treatment of diabetic nephropathy.
October 2006, Nature clinical practice. Nephrology,
H H Parving, and A R Andersen, and U M Smidt, and P A Svendsen
Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
September 2017, Journal of the American Society of Nephrology : JASN,
Copied contents to your clipboard!